about
Donepezil for mild cognitive impairmentClassification models for early identification of persons at risk for dementia in primary care: an evaluation in a sample aged 80 years and older.Central auditory dysfunction in older persons with memory impairment or Alzheimer dementia.Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsRoles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.Structured approach to patients with memory difficulties in family practiceNeuropsychological test selection for cognitive impairment classification: A machine learning approachAnti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults.Diagnosing early onset dementia and then what? A frustrating system of aftercare resources.Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.The implicit function as squashing time model: a novel parallel nonlinear EEG analysis technique distinguishing mild cognitive impairment and Alzheimer's disease subjects with high degree of accuracy.The relationship among unawareness of memory impairment, depression, and dementia in older adults with memory impairment in Singapore.Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.Application of AD8 questionnaire to screen very mild dementia in Taiwanese.Approche structurée en pratique familiale pour les patients ayant des problèmes de mémoire.
P2860
Q24245534-785BD602-F547-48BD-B128-DE35DB472393Q33837414-DA8D4FD4-6A30-4800-8819-B2EFC9D86A94Q33853819-3379395A-EE4A-4F0C-933E-CAE3AF43F043Q34965949-10265D8E-4A27-4072-A59E-23EECA865B8DQ35016920-F0972FDB-CCC7-4A44-BEF8-BE164F49B166Q35129327-D1B3E6E6-7A4B-4BF8-BC9B-C750D6FF9FE8Q36680461-BAD40964-19B6-4A3C-A272-93F489B7F339Q36733640-80418D22-2353-4FD0-83E1-8B1065290863Q37101754-6410344B-5A0A-4C38-821D-31046B9DA0EFQ37333228-0AB0E313-00D4-4D7A-B726-7787B78264D3Q37979786-04155F87-4C23-4A6F-ADB4-253246C89D4BQ38597149-9A5B9542-04E4-461A-B0C1-FB8C42F22294Q39285908-79C28E67-E241-4AB2-B2C0-8386036D7248Q41895793-A35ED8B6-FC49-4EB0-A255-B68F8E96A296Q47703876-0DBFFCA7-E255-4E33-9A4F-143F9DEAEE76Q50560910-0435CB13-BFFF-4175-B9BF-0A926F616BD1Q51048025-8FAE4112-020F-40FC-9F8B-FC5C9B15629EQ55545911-F89A90E4-ECAC-486B-B333-A782A20808C2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Alzheimer's disease: the benefits of early treatment.
@ast
Alzheimer's disease: the benefits of early treatment.
@en
type
label
Alzheimer's disease: the benefits of early treatment.
@ast
Alzheimer's disease: the benefits of early treatment.
@en
prefLabel
Alzheimer's disease: the benefits of early treatment.
@ast
Alzheimer's disease: the benefits of early treatment.
@en
P2860
P1476
Alzheimer's disease: the benefits of early treatment.
@en
P2093
S G Gauthier
P2860
P356
10.1111/J.1468-1331.2005.01322.X
P478
12 Suppl 3
P577
2005-10-01T00:00:00Z